Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
HK |
|
E
|
Emerald Leisures Ltd
BSE:507265
|
IN |
|
Southstone Minerals Ltd
XTSX:SML
|
CA |
|
Magnitogorskiy Metallurgicheskiy Kombinat PAO
MOEX:MAGN
|
RU |
|
Embla Medical hf
CSE:EMBLA
|
IS |
|
Doosan Bobcat Inc
KRX:241560
|
KR |
|
D
|
Dala Energi AB (publ)
F:ZW1
|
SE |
|
M
|
MPC Energy Solutions NV
OSE:MPCES
|
NL |
|
Fortitude Gold Corp
OTC:FTCO
|
US |
|
Hokuriku Electric Power Co
TSE:9505
|
JP |
Wall Street
Price Targets
Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 11.22 HKD with a low forecast of 11.11 HKD and a high forecast of 11.55 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's stock price target?
Price Target
11.22
HKD
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 11.22 HKD with a low forecast of 11.11 HKD and a high forecast of 11.55 HKD.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Revenue forecast?
Projected CAGR
20%
For the last 13 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's revenue is 12%. The projected CAGR for the next 2 years is 20%.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Operating Income forecast?
Projected CAGR
37%
For the last 13 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's operating income is 12%. The projected CAGR for the next 2 years is 37%.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income forecast?
Projected CAGR
33%
For the last 13 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's net income is 7%. The projected CAGR for the next 2 years is 33%.
